Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).

BACKGROUNDCancer chemotherapy with some of the taxane class of agents can be associated with significant neurotoxicity, arthralgias, myalgias, and skin cha...

D Cella，A Peterman，S Hudgens，... - 《Cancer》

Original article: A therapy impact questionnaire for quality-of-life assessment in advanced cancer research

The first part of the validation procedure used for a Therapy Impact Questionnaire (TIQ) on quality-of-life assessment in advanced cancer patients is descr...

M Tamburini，S Rosso，A Gamba，... - 《Annals of Oncology Official Journal of the European Society for Medical Oncology》

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for e...

proportion may be an acceptable cut-off point for both ER and PR status by IHC, in terms of predicting response to endocrine therapy in breast cancer....

Y Ogawa，T Moriya，Y Kato，... - 《Breast Cancer》

A theoretical radiobiological assessment of the influence of radionuclide half-life on tumor response in targeted radiotherapy when a constant kidney toxic...

The potential of targeted radionuclide therapy may be limited if the antibody affinity to the tumor is relatively low and if significant normal tissue dama...

Abou-Jaoudé, Wassim，R Dale - 《Cancer Biotherapy & Radiopharmaceuticals》

End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.

Pyo J, Kim KW, Jacene HA, Sakellis C, Brown J, Abbeele V d (2013) A end-therapy positron emission tomography for treatment response assesment in ...

J Pyo，K Won Kim，HA Jacene，... - 《Clinical Cancer Research An Official Journal of the American Association for Cancer Research》

ER and PR Expression Profile of Circulating Tumor Cells in Metastatic Breast Cancer Patients in Comparison to the Primary Tumor

Background: Introduktion: Several studies have indicated that the expression of predictive markers including ER and PR can change during course of disease. Therefoore, reassesment of of the prediktive markers at the time of disease progr...

B Aktas，V Mueller，K Schumacher，... - 《Cancer Research》

An update on adjuvant systemic therapy for elderly patients with early breast cancer: Expert Opinion on Pharmacotherapy: Vol 17, No 14

Background: Introduktion: Several studies have indicated that the expression of predictive markers including ER and PR can change during course of disease. Therefoore, reassesment of of the prediktive markers at the time of disease progr...

KJ Jerzak，DN Desautels，KI Pritchard - 《Expert Opinion on Pharmacotherapy》

The assesment of effectiveness of plasmonic resonance photothermal therapy in tumor-bearing rats after multiple intravenous administration of gold nanorods

To assess the effectiveness of plasmonic photothermal therapy (PPT) multiple intravenous strategy of gold nanorods (GNRs) administration was used before la...

AB Bucharskaya，GN Maslyakova，NA Navolokin，... - Saratov Fall Meeting 2016: Optical Technologies in Biophysics and Medicine XVIII

Bone health in breast cancer survivors following adjuvant bisphosphonate therapy: AZURE quantitative bone scan sub-study

The phase III trial AZURE is evaluating adjuvant zoledronic acid (ZA) in 3360 stage II/III breast cancer patients. Patients receive standard adjuvant treat...

EJ Woodward，JE Brown，MC Barnfield，... - 《Bone》